These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19172139)

  • 21. Brugada syndrome and vasovagal syncope.
    Patruno N; Pontillo D
    Pacing Clin Electrophysiol; 2006 Feb; 29(2):215; author reply 216. PubMed ID: 16492314
    [No Abstract]   [Full Text] [Related]  

  • 22. Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely.
    Tung R; Swerdlow CD
    Circulation; 2009 Sep; 120(10):825-7. PubMed ID: 19704090
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk assessment with cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Gosling OE; Bellenger N; Spurrell P
    Heart; 2009 Nov; 95(22):1843. PubMed ID: 19875370
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of lipid-altering therapies on ventricular arrhythmias and sudden cardiac death.
    Majmudar MD; Tompkins C; Bachmann JM; Blumenthal RS; Marine JE
    Cardiol Rev; 2009; 17(2):60-9. PubMed ID: 19367147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Implantable cardioverter defibrillator].
    Tanaka S; Ikeshita M; Shoji T
    Kokyu To Junkan; 1993 Apr; 41(4):357-63. PubMed ID: 8516574
    [No Abstract]   [Full Text] [Related]  

  • 26. Implantable cardioverter-defibrillators.
    Kutalek SP; Dreifus LS
    Adv Intern Med; 1993; 38():421-38. PubMed ID: 8438649
    [No Abstract]   [Full Text] [Related]  

  • 27. Sudden cardiac death of two heart transplant patients with correctly functioning implantable cardioverter defibrillators.
    Marzoa-Rivas R; Perez-Alvarez L; Paniagua-Martin MJ; Ricoy-Martinez E; Flores-Ríos X; Rodriguez-Fernandez JA; Salgado-Fernandez J; Franco-Gutierrez R; Cuenca-Castillo JJ; Herrera JM; Capdevila A; Vazquez P; Castro-Beiras A; Crespo-Leiro MG
    J Heart Lung Transplant; 2009 Apr; 28(4):412-4. PubMed ID: 19332273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Automatic implantable cardioverter-defibrillators in treating life-threatening ventricular tachyarrhythmias].
    Bodar' VI; Razymovskii VA; Belokon' NS
    Klin Med (Mosk); 1996; 74(7):58-9. PubMed ID: 8992121
    [No Abstract]   [Full Text] [Related]  

  • 29. Sudden death on the treadmill.
    Sabbath AM; Indik JH
    Am J Med; 2006 Nov; 119(11):932-4. PubMed ID: 17071159
    [No Abstract]   [Full Text] [Related]  

  • 30. Implantable cardioverter defibrillators in athletes: rationale for use and issues surrounding return to play.
    Lawless CE
    Curr Sports Med Rep; 2008; 7(2):86-92. PubMed ID: 22908402
    [No Abstract]   [Full Text] [Related]  

  • 31. Reappraisal of implant testing of implantable cardioverter defibrillators.
    Swerdlow CD
    J Am Coll Cardiol; 2004 Jul; 44(1):92-4. PubMed ID: 15234414
    [No Abstract]   [Full Text] [Related]  

  • 32. Impeding Sudden Cardiac Death Despite Subcutaneous Implantable Defibrillator Due to Fatal Crosstalk.
    Akin I; Röger S; Borggrefe M; Kuschyk J
    J Cardiovasc Electrophysiol; 2016 May; 27(5):613-4. PubMed ID: 26511798
    [No Abstract]   [Full Text] [Related]  

  • 33. Lessons from a population: the limitations of left ventricular ejection fraction as the major determinant for primary prevention implantable cardioverter-defibrillators.
    Groh WJ
    J Am Coll Cardiol; 2006 Mar; 47(6):1167-8. PubMed ID: 16545647
    [No Abstract]   [Full Text] [Related]  

  • 34. Evolution of the implantable cardioverter defibrillator.
    Crystal E; Connolly SJ
    Lancet; 2002 Apr; 359(9315):1362-3. PubMed ID: 11978329
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of high defibrillation threshold.
    Uyguanco ER; Berger A; Budzikowski AS; Gunsburg M; Kassotis J
    Expert Rev Cardiovasc Ther; 2008 Oct; 6(9):1237-48. PubMed ID: 18939911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventricular fibrillation: new insights into mechanisms.
    Weiss JN; Chen PS; Wu TJ; Siegerman C; Garfinkel A
    Ann N Y Acad Sci; 2004 May; 1015():122-32. PubMed ID: 15201154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Troubleshooting implantable cardioverter-defibrillator related problems.
    van Erven L; Schalij MJ
    Heart; 2008 May; 94(5):649-60. PubMed ID: 18411360
    [No Abstract]   [Full Text] [Related]  

  • 38. [The implantable cardioverter-defibruillators used in the prophylaxis of sudden cardiac death].
    Kluizhev VM; Ardashev VN; Ardashev AV; Zheliakov EG
    Voen Med Zh; 2004 Sep; 325(9):26-30. PubMed ID: 15537098
    [No Abstract]   [Full Text] [Related]  

  • 39. Implantable cardioverter-defibrillator and mortality in dialysis patients.
    Saravanan P; Davidson NC
    Am J Cardiol; 2009 Jun; 103(11):1623-4. PubMed ID: 19463528
    [No Abstract]   [Full Text] [Related]  

  • 40. Implantable cardioverter defibrillators save lives from lightning-related electrocution too!
    Kondur AK; Afonso LC; Berenbom LD; Lakkireddy DR
    Pacing Clin Electrophysiol; 2008 Feb; 31(2):256-7. PubMed ID: 18233984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.